MedPath

安徽美誉制药有限公司

Ownership
-
Established
2010-12-20
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

5

NMPA:5

Drug Approvals

Cefoperazone Sodium and Sulbactam Sodium for Injection

Product Name
注射用头孢哌酮钠舒巴坦钠
Approval Number
国药准字H20059198
Approval Date
Aug 17, 2020
NMPA

Cefoperazone Sodium and Sulbactam Sodium for Injection

Product Name
注射用头孢哌酮钠舒巴坦钠
Approval Number
国药准字H20083969
Approval Date
Aug 10, 2020
NMPA

Cefoxitin Sodium for Injection

Product Name
注射用头孢西丁钠
Approval Number
国药准字H20058824
Approval Date
Jul 10, 2020
NMPA

Cefonicid Sodium for Injection

Product Name
注射用头孢尼西钠
Approval Number
国药准字H20058725
Approval Date
Mar 2, 2020
NMPA

Cefonicid Sodium for Injection

Product Name
注射用头孢尼西钠
Approval Number
国药准字H20058724
Approval Date
Mar 2, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.